GLP-1s: One Part of a Holistic Care Strategy
Across employer populations nationwide, GLP-1 medications are becoming a more common part of weight management and chronic condition care strategies.
Prices are beginning to come down. New formulations, including oral options, are expanding access. And for many individuals, these therapies are proving to be powerful tools in managing weight and chronic conditions like diabetes, heart disease, and high blood pressure.
As GLP-1s become more accessible, one thing is becoming increasingly clear: medication alone is not a long-term strategy.
Why GLP-1s Matter for Chronic Disease and Cost
GLP-1 medications were initially developed for diabetes management, but their benefits extend far beyond blood sugar control. Clinical outcomes increasingly show improvements across multiple chronic conditions, including:
- Type 2 diabetes
- Cardiovascular disease
- Hypertension
- Obesity-related comorbidities
When chronic conditions are better controlled, downstream costs tend to follow. These include fewer complications, hospitalizations, and lower utilization over time. From a population health perspective, GLP-1s can play a meaningful role in cost containment when used appropriately and strategically.
With expanded access, including pill-based options that reduce barriers for some populations, more members are now able to engage with these therapies.
The Critical Question: What Happens When the Medication Stops?
GLP-1s can be highly effective while they’re being used. Many individuals experience meaningful improvements in weight, blood sugar control, and other markers of chronic disease. But medication is only one part of the equation.
If sustainable lifestyle changes aren’t developed alongside the medication, there is a real risk that progress may stall or reverse once treatment is paused or discontinued. Coverage changes, affordability concerns, side effects, or personal circumstances can all impact long-term use. When that happens, members who haven’t built supportive habits may find themselves right back where they started.
That’s not a failure of the drug. It’s a reminder that weight management and chronic disease care are not one-dimensional problems. Long-term success requires addressing nutrition, physical activity, behavior change, and ongoing support so improvements can be maintained with or without medication.
Medication Works Best When It’s Part of a Comprehensive Plan
This is where care management matters.
Sustainable health outcomes come from pairing clinical tools with behavioral support, education, and accountability. Members need help building habits that last beyond a prescription, whether they remain on medication long-term or not.
MedWatch Senior Vice President of Medical Management, Amy Tennis, RN, MBA, CCM explains, “At MedWatch, we view GLP-1s as a tool, not a permanent solution, for managing obesity as a chronic condition. Our weight management program pairs individualized GLP-1 microdosing with behavioral modification and lifestyle coaching to support adherence, manage side effects, and build sustainable nutrition and activity habits. As members are gradually weaned off medication, ongoing coaching reinforces long-term behavior change, reduces the risk of relapse, and drives stronger ROI for plans.”
That’s why MedWatch approaches GLP-1 utilization as one component of a broader, integrated care strategy, not a standalone solution.
Supporting the Whole Journey with MedWatch
MedWatch programs are designed to wrap around members before, during, and after medication use to support lasting change:
- MedWatch Weight Management Program
Helps members address weight in a structured, supportive way that goes beyond the scale, focusing on behaviors, barriers, and long-term success. - Health Coaches
Provide one-on-one guidance, motivation, and accountability, helping members translate clinical recommendations into daily habits. - Living Healthy Program
Supports members with diabetes through education, monitoring, and lifestyle support that complements pharmacologic treatment and reduces long-term risk.Together, these programs help ensure that when GLP-1s are used, they’re used thoughtfully and that members aren’t left without support if circumstances change.
The Opportunity with GLP-1s
GLP-1 medications represent real progress. Increased access is a positive step forward, and its impact on chronic disease management is undeniable.
But the greatest opportunity for better outcomes and better cost control comes when these therapies are integrated into a comprehensive care management model that supports lasting behavior change.
That’s how we move from short-term results to long-term health and from rising costs to sustainable solutions.
GLP-1 Medications: Common Questions Employers and Brokers Ask
What are GLP-1 medications?
GLP-1 medications are a class of drugs originally developed to help manage Type 2 diabetes. They work by regulating appetite, improving insulin response, and slowing digestion. Today, they are also commonly used to support weight management and reduce the risk associated with chronic conditions such as heart disease and high blood pressure.
Are GLP-1 medications a long-term solution for weight management?
GLP-1 medications can be effective while they are being used, but they are not a standalone long-term solution. Sustainable weight management typically requires lifestyle changes, behavioral support, and ongoing care. Without those elements, progress may be difficult to maintain if the medication is paused or discontinued.
How do GLP-1 medications impact healthcare costs?
When used appropriately, GLP-1 medications can help improve control of chronic conditions, which may reduce downstream costs such as hospitalizations and complications. However, medication costs alone do not guarantee long-term savings. The greatest cost-containment impact occurs when GLP-1s are part of a comprehensive care management strategy.
Why is care management important when using GLP-1 medications?
Care management helps members build sustainable habits related to nutrition, physical activity, and behavior change. This support is critical for maintaining health improvements both during and after medication use. Without care management, individuals may struggle to sustain results over time.
What happens if a member stops taking a GLP-1 medication?
If a member stops taking a GLP-1 medication without having established supportive lifestyle changes, there is a risk that weight or chronic condition indicators may return to previous levels. Ongoing coaching, education, and monitoring can help reduce this risk and support long-term success.
How does MedWatch support members using GLP-1 medications?
MedWatch supports members through integrated programs that complement medication use, including the Weight Management Program, Health Coaches, and the Living Healthy Program for diabetes management. These programs focus on education, behavior change, and accountability to support lasting health outcomes.
How can employers manage GLP-1 utilization responsibly?
Employers can support responsible GLP-1 use by pairing medication access with comprehensive care management, education, and coaching. This approach helps ensure medications are used appropriately, supports member health, and improves the likelihood of sustainable outcomes and cost control.